Literature DB >> 29396171

ATP1A3 spectrum disorders: A video-documented history of 7 genetically confirmed early onset cases.

Michela Stagnaro1, Livia Pisciotta1, Marcella Gherzi1, Maja Di Rocco2, Fiorella Gurrieri3, Elena Parrini4, Giulia Prato1, Edvige Veneselli1, Elisa De Grandis5.   

Abstract

Mutations in the ATP1A3 gene, which encodes the alpha3-subunit of sodium-potassium ATPase, are related to a spectrum of neurological diseases including Rapid onset Dystonia-Parkinsonism (RDP), Alternating Hemiplegia of Childhood (AHC) and Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy and Sensorineural hearing loss (CAPOS) syndrome. Moreover, an increasing number of patients with intermediate and non classical phenotypes have been reported. Herein we describe 7 patients with 6 different de novo ATP1A3 mutations, and we focus on paroxysmal and chronic movement disorders with the help of video documentation. Our cases confirm that ATP1A3-related neurological disorders make up a phenotypic continuum rather than overlapping syndromes, in which early onset dystonia, ataxia and paroxysmal episodes with triggering or worsening factors are key diagnostic clues. Moreover, our experience suggests that ATP1A3 gene analysis should be extended both to children with channelopathy-like spells and to patients with early onset, fever-related encephalopathy.
Copyright © 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATP1A3; Dystonia; Genotype; Paroxysmal; Phenotype; Triggers

Mesh:

Substances:

Year:  2018        PMID: 29396171     DOI: 10.1016/j.ejpn.2018.01.010

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  CAPOS Syndrome: A Rare ATP1A3-Related Disorder.

Authors:  Indar K Sharawat; Ananthanarayanan Kasinathan; Renu Suthar; Naveen Sankhyan
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

Review 2.  ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.

Authors:  Philippe A Salles; Ignacio F Mata; Tobias Brünger; Dennis Lal; Hubert H Fernandez
Journal:  Front Neurol       Date:  2021-04-01       Impact factor: 4.003

3.  Chinese patients with p.Arg756 mutations of ATP1A3: Clinical manifestations, treatment, and follow-up.

Authors:  Weihua Zhang; Jiuwei Li; Xiuwei Zhuo; Ji Zhou; Weixing Feng; Shuai Gong; Xiaotun Ren; Changhong Ding; Tongli Han; Fang Fang
Journal:  Pediatr Investig       Date:  2022-02-25

Review 4.  Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.

Authors:  Mateusz Biela; Malgorzata Rydzanicz; Krystyna Szymanska; Karolina Pieniawska-Smiech; Aleksandra Lewandowicz-Uszynska; Joanna Chruszcz; Lucyna Benben; Malgorzata Kuzior-Plawiak; Pawel Szyld; Aleksandra Jakubiak; Leszek Szenborn; Rafal Ploski; Robert Smigiel
Journal:  Mol Genet Genomic Med       Date:  2021-08-02       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.